Moreover, we found that the histone methyltransferase EZH2 [61] was over-expressed in human HCCs and promoted HCC cell growth and tumorigenicity at least partially through activation of Wnt/β-catenin signaling [24], [62]. The gene discussed is PRDM9; the disease is hepatocellular carcinoma.